ADMA Biologics
ADMA
#3195
Rank
HK$29.27 B
Marketcap
HK$123.84
Share price
-1.12%
Change (1 day)
197.20%
Change (1 year)

Revenue for ADMA Biologics (ADMA)

Revenue in 2024 (TTM): HK$2.98 Billion

According to ADMA Biologics 's latest financial reports the company's current revenue (TTM ) is HK$2.98 Billion. In 2023 the company made a revenue of HK$2.01 Billion an increase over the revenue in the year 2022 that were of HK$1.20 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ADMA Biologics from 2010 to 2024

2013201620192022$0.5B$1B$1.5B$2B$2.5B$3B0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) HK$2.98 B48.1%
2023 HK$2.01 B67.52%
2022 HK$1.20 B90.74%
2021 HK$0.63 B92.84%
2020 HK$0.32 B43.19%
2019 HK$0.22 B71.85%
2018 HK$0.13 B-25.2%
2017 HK$0.17 B115.1%
2016 HK$82.67 M48.6%
2015 HK$55.63 M21.25%
2014 HK$45.88 M92.89%
2013 HK$23.78 M174.46%
2012 HK$8.66 M
2011 N/A
2010 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
HK$6.59 B 121.32%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$4.84 B 62.65%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA